MTOR and ovarian cancer: We identified about 37 activated TFs from three sub-groups of ovarian cancer, as well as a set of up-stream signaling pathways linking to these TFs, e.g., WNT, TP53, MYC, AKT, RAS, mTOR, PDGFRA signaling pathways.